Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v4-FR | Version v3-EN | |
---|---|---|
Language | French | English |
Date Updated | 2020-05-19 | 2020-05-19 |
Drug Identification Number | 00658413 | 00658413 |
Brand name | BAXEDIN LIQ 20% | BAXEDIN LIQ 20% |
Common or Proper name | Baxedin® 20% | Baxedin® 20% |
Company Name | OMEGA LABORATORIES LIMITED | OMEGA LABORATORIES LIMITED |
Ingredients | CHLORHEXIDINE GLUCONATE | CHLORHEXIDINE GLUCONATE |
Strength(s) | 20% | 20% |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | TOPICAL TOPICAL | TOPICAL TOPICAL |
Packaging size | 500 mL | 500 mL |
ATC code | D08AC | D08AC |
ATC description | ANTISEPTICS AND DISINFECTANTS | ANTISEPTICS AND DISINFECTANTS |
Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
Anticipated start date | ||
Actual start date | 2020-04-17 | 2020-04-17 |
Estimated end date | 2020-04-30 | 2020-04-30 |
Actual end date | 2020-05-11 | 2020-05-11 |
Shortage status | Resolved | Resolved |
Tier 3 Status | No | No |
Company comments | ||
Health Canada comments |